ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim

New license and supply agreement will see ImaginAb supply Boehringer Ingelheim with its market leading CD8 ImmunoPET technology LOS ANGELES, July 23, 2021 -- (Healthcare Sales & Marketing Network) -- ImaginAb Inc, a market leading global biotechnology ... Biopharmaceuticals, Radiology, Licensing ImaginAb, Boehringer Ingelheim, radiopharmaceuticals, ImmunoPET
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news